← Leaderboards
Susan S Huang
University Of California-Irvine
$35,827,644
Attributed
$47,272,589
Total exposure
19
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$35,146,151 · 16
AHRQ$14,563,249 · 4
CDC$13,082,199 · 2
By mechanism
R01$14,563,249 · 4
U54$13,082,199 · 2
U19$11,801,535 · 3
U01$8,306,982 · 2
UH3$7,636,449 · 4
P01$4,379,289 · 3
Top collaborators
- Richard Platt19 shared
- Stuart H. Cohen3 shared
- Kenneth P. Kleinman3 shared
- Michael Klompas1 shared
Most similar at University Of California-Irvine
Same institution · by research overlap
- Ashlee Miriam Earl$16,638,111
- Bruce Y Lee$13,790,157
- Katrine Whiteson$213,742
- Weian Zhao$7,748,750
Others in their field
Top investigators on “Hospitals”
- Larry Arthur$288,323,000
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$230,275,254
- Judith S. Currier · University Of California Los Angeles$223,149,861
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$221,207,102
- Lawrence Corey · Fred Hutchinson Cancer Center$217,829,567
- Daniel R Kuritzkes · Brigham And Women'S Hospital$179,610,394
Research focus
HospitalsTransmission ProcessPathogenInfectionPreventionPrevalenceHospitalizationProgramsEpidemiologyIntensive Care UnitsMorbidity - Disease RatePreventHealthcareBaseCaringInfection PreventionProspectiveResistanceRandomizedOrganismRandomized TrialAreaEvaluationWard
Grant awards (56)
MDRO Carriage, Transmission, Sequelae, and Prevention in Nursing Homes$3,252,905
U19 · FY2025 · AI · contact PI
Epidemiology of MDRO Carriage in Nursing Homes$2,287,304
U19 · FY2025 · AI · contact PI
The DECREASE SSI Trial (Decolonization to Reduce After-Surgery Events of Surgical Site Infection)$500,000
R01 · FY2025 · HS · contact PI
Administrative Core$260,803
U19 · FY2025 · AI · contact PI
MDRO Carriage, Transmission, Sequelae, and Prevention in Nursing Homes$3,220,982
U19 · FY2024 · AI · contact PI
Epidemiology of MDRO Carriage in Nursing Homes$1,692,089
U19 · FY2024 · AI · contact PI
INSPIRE (INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection for Patients): The INSPIRE-ASP Trial for Intra-Abdominal and Skin and Soft Tissue Infections$1,499,671
U01 · FY2024 · AI
Administrative Core$1,087,452
U19 · FY2024 · AI · contact PI
The DECREASE SSI Trial (Decolonization to Reduce After-Surgery Events of Surgical Site Infection)$500,000
R01 · FY2024 · HS · contact PI
MDRO Carriage, Transmission, Sequelae, and Prevention in Nursing Homes$2,853,098
P01 · FY2023 · AI · contact PI
INSPIRE (INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection for Patients): The INSPIRE-ASP Trial for Intra-Abdominal and Skin and Soft Tissue Infections$1,536,833
U01 · FY2023 · AI
Epidemiology of MDRO Carriage in Nursing Homes$1,327,053
P01 · FY2023 · AI · contact PI
The DECREASE SSI Trial (Decolonization to Reduce After-Surgery Events of Surgical Site Infection)$500,000
R01 · FY2023 · HS · contact PI
Administrative Core$199,138
P01 · FY2023 · AI · contact PI
INSPIRE (INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection for Patients): The INSPIRE-ASP Trial for Intra-Abdominal and Skin and Soft Tissue Infections$1,550,732
U01 · FY2022 · AI
The DECREASE SSI Trial (Decolonization to Reduce After-Surgery Events of Surgical Site Infection)$494,835
R01 · FY2022 · HS · contact PI
INSPIRE (INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection for Patients): The INSPIRE-ASP Trial for Intra-Abdominal and Skin and Soft Tissue Infections$1,573,993
U01 · FY2021 · AI
INSPIRE (INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection for Patients): The INSPIRE-ASP Trial for Intra-Abdominal and Skin and Soft Tissue Infections$1,646,462
U01 · FY2020 · AI
Epicenter IV: Harvard Pilgrim-UCI Center for HAI Prevention COVID-19 Supplement$600,000
U54 · FY2019 · CK
Epicenter IV: Harvard Pilgrim-UCI Center for HAI Prevention$500,000
U54 · FY2019 · CK
Epicenter IV: Harvard Pilgrim-UCI Center for HAI Prevention$624,942
U54 · FY2018 · CK
Decreasing Bioburden to Reduce Healthcare-Associated Infections and Readmissions$1,444,424
UH3 · FY2017 · AI · contact PI
ConProject-001$501,514
UH3 · FY2017 · AI · contact PI
Epicenter IV: Harvard Pilgrim-UCI Center for HAI Prevention$499,999
U54 · FY2017 · CK
ConProject-002$490,534
UH3 · FY2017 · AI · contact PI
ConProject-003$452,376
UH3 · FY2017 · AI · contact PI
Epicenter IV: Harvard Pilgrim-UCI Center for HAI Prevention$5,199,994
U54 · FY2016 · CK
Decreasing Bioburden to Reduce Healthcare-Associated Infections and Readmissions$1,467,519
UH3 · FY2016 · AI · contact PI
PROTECT Trial: Protecting nursing home residents from infections and readmissions$2,328,617
R01 · FY2015 · HS · contact PI
Decreasing Bioburden to Reduce Healthcare-Associated Infections and Readmissions$1,499,265
UH3 · FY2015 · AI · contact PI
Epicenters III: Translational Research to Prevent Healthcare Associated Infection$1,000,000
U54 · FY2015 · CK
Epicenters III: Translational Research to Prevent Healthcare Associated Infection$799,990
U54 · FY2015 · CK
The SAFER Lines Project: Standardizing Assessment For Effective Response$496,764
R01 · FY2015 · HS · contact PI
Epicenters III: Translational Research to Prevent Healthcare Associated Infection$332,618
U54 · FY2015 · CK
Decreasing Bioburden to Reduce Healthcare-Associated Infections and Readmissions$1,780,817
UH3 · FY2014 · AI · contact PI
Epicenters III: Translational Research to Prevent Healthcare Associated Infection$350,000
U54 · FY2014 · CK
Epicenters III: Translational Research to Prevent Healthcare Associated Infection$332,618
U54 · FY2014 · CK
Epicenters III: Translational Research to Prevent Healthcare Associated Infection$332,618
U54 · FY2013 · CK
Epicenters III: Translational Research to Prevent Healthcare Associated Infection$300,000
U54 · FY2013 · CK
DECREASING BIOBURDEN TO REDUCE HEALTHCARE-ASSOCIATED INFECTIONS AND READMISSIONS$199,535
UH2 · FY2013 · AT · contact PI
Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance$1,935,641
R01 · FY2012 · HS · contact PI
Decreasing Bioburden to Reduce Healthcare-Associated Infections and Readmissions$810,518
UH2 · FY2012 · AT · contact PI
Epicenters III: Translational Research to Prevent Healthcare Associated Infection$332,618
U54 · FY2012 · CK
Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance$3,999,999
R01 · FY2011 · HS · contact PI
Public Health Prevention Fund (PPHF) Ventilator Associated Pneumonia ACA$1,544,184
U54 · FY2011 · CK
Epicenters III: Translational Research to Prevent Healthcare Associated Infection$332,618
U54 · FY2011 · CK
Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance$3,807,393
R01 · FY2010 · HS · contact PI
Comparative Effectiveness of MRSA Decolonization Strategies$1,248,355
RC4 · FY2010 · AI · contact PI
Modeling Health System Infectious Disease Data$499,291
U01 · FY2010 · GM · contact PI
Improving Assessment of MRSA & VRE Transmission in ICUs$133,920
K23 · FY2009 · AI · contact PI
Improving Assessment of MRSA & VRE Transmission in ICUs$133,920
K23 · FY2008 · AI · contact PI
Improving Assessment of MRSA & VRE Transmission in ICUs$133,920
K23 · FY2007 · AI · contact PI
Improving Assessment of MRSA & VRE Transmission in ICUs$133,920
K23 · FY2006 · AI · contact PI
Improving Assessment of MRSA &VRE Transmission in ICUs$133,920
K23 · FY2005 · AI
Modeling Antimicrobial Resistance in Communities$50,116
F32 · FY2002 · AI
Modeling Antimicrobial Resistance in Communities$43,772
F32 · FY2001 · AI